false
Hamburger Menu
Catalog
JTO Clinical and Research Reports, August 2022, Vo ...
JTO Clinical and Research Reports, August 2022, Volume 3, Issue 8
Journal | English | 2022
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
Editorials
Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (
RET
Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
Original Articles:
Racial and Ethnic Trends and Disparities in NSCLC
Association Between
EGFR
and
ALK
Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC
Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities
Case Reports
Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With
BAP1
Germline Mutation: A Case Report
Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic
ALK
-Rearranged NSCLC: A Case Report
Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
Distinct NSCLC
EGFR
Variants in a Family With Li-Fraumeni Syndrome: Case Report
Brief Reports
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced
ALK
-Positive NSCLC
About JTO Clinical and Research Reports
JTO Clinical and Research Reports
is the official open access journal of the
International Association for the Study of Lung Cancer
. It aims to complement the
Journal of Thoracic Oncology
by offering authors a gold open access publication option and publishing the following article types in particular:
Phase I trials
Well performed single-arm phase II trials
Subset analyses of published trials
Impactful retrospective Studies
Database analysis
Large institutional series
High-quality case reports
Region-specific clinical trials
Subspecialty thoracic oncology studies
Selected high-quality meeting reports
As an open access journal with no subscription charges,
JTO CRR
requires authors to pay a
fee
to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
×
JTO Clinical and Research Reports, August 2022, Volume 3, Issue 8 Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English